IVFhCG 1500 Injection contains Human Chorionic Gonadotropin (hCG) at a concentration of 1500 IU per dose. It is indicated for use in assisted reproductive technologies, particularly in in vitro fertilization (IVF) protocols to trigger final oocyte maturation and ovulation. The hCG hormone mimics the natural luteinizing hormone (LH) surge, facilitating the resumption of meiosis in oocytes and promoting luteal phase support. IVFhCG 1500 Injection is administered intramuscularly or subcutaneously under medical supervision, typically timed to optimize follicular development and improve the chances of successful fertilization and implantation. It is essential to adhere to prescribed dosing regimens to minimize risks such as ovarian hyperstimulation syndrome (OHSS). Contraindications include hypersensitivity to hCG or any component of the formulation, hormone-sensitive tumors, and uncontrolled thyroid or adrenal disorders. Common adverse effects may include injection site reactions, headache, fatigue, and mild abdominal discomfort. Careful patient monitoring during treatment is advised to detect any adverse events promptly. IVFhCG 1500 Injection should be used as part of a comprehensive fertility treatment plan under the guidance of a qualified reproductive endocrinologist. Proper storage conditions and handling instructions must be followed to maintain product efficacy and safety.